Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (381-390 of 415) with videos related to

Pageof 42
Sort By:
Biorxiv : the Preprint Server for Biology|August 31, 2023
Mycobacterium tuberculosis infection associated immune perturbations correlate with antiretroviral immunityBurcu Tepekule Mueller, Lisa Joerimann, Corinne D Schenkel, et al.
Frontiers in Pharmacology|December 2, 2024
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
BMC Infectious Diseases|October 11, 2024
Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort StudyKatharina Kusejko, Roger D Kouyos, Enos Bernasconi, et al.
The Journal of Experimental Medicine|May 26, 2018
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activityClaus Kadelka, Thomas Liechti, Hanna Ebner, et al.
The Journal of Infectious Diseases|August 26, 2025
Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People with HIV: the Swiss HIV Cohort StudyMarco Labarile, Isabella C Schoepf, Chloé Pasin, et al.
International Journal of Epidemiology|August 7, 2021
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)Alexandra U Scherrer, Anna Traytel, Dominique L Braun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2022
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 EpidemicsKatharina Kusejko, Nadine Tschumi, Sandra E Chaudron, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Iscience|November 18, 2024
Transcriptional profile of <i>Mycobacterium tuberculosis</i> infection in people living with HIVBurcu Tepekule, Lisa Jörimann, Corinne D Schenkel, et al.
Pageof 42

Showing results (381-390 of 415) with videos related to

Sort By:
Pageof 42
Biorxiv : the Preprint Server for Biology|August 31, 2023
Mycobacterium tuberculosis infection associated immune perturbations correlate with antiretroviral immunityBurcu Tepekule Mueller, Lisa Joerimann, Corinne D Schenkel, et al.
Frontiers in Pharmacology|December 2, 2024
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
BMC Infectious Diseases|October 11, 2024
Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort StudyKatharina Kusejko, Roger D Kouyos, Enos Bernasconi, et al.
The Journal of Experimental Medicine|May 26, 2018
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activityClaus Kadelka, Thomas Liechti, Hanna Ebner, et al.
The Journal of Infectious Diseases|August 26, 2025
Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People with HIV: the Swiss HIV Cohort StudyMarco Labarile, Isabella C Schoepf, Chloé Pasin, et al.
International Journal of Epidemiology|August 7, 2021
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)Alexandra U Scherrer, Anna Traytel, Dominique L Braun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2022
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 EpidemicsKatharina Kusejko, Nadine Tschumi, Sandra E Chaudron, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Iscience|November 18, 2024
Transcriptional profile of <i>Mycobacterium tuberculosis</i> infection in people living with HIVBurcu Tepekule, Lisa Jörimann, Corinne D Schenkel, et al.
Pageof 42